| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |